van der Ploeg, Augustinus P T <br/><br/>
Melanoma patients with an unknown primary tumor site have a better outcome than those with a known primary following therapeutic lymph node dissection for macroscopic (clinically palpable) nodal disease.  [electronic resource] 

 -  Annals of surgical oncology  Sep 2014 
 - 3108-16 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1534-4681 
<br/><br/><label>Standard No.: </label>10.1245/s10434-014-3679-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Lymph Node Excision--mortality<br/>Male<br/>Melanoma--mortality<br/>Middle Aged<br/>Neoplasm Staging<br/>Neoplasms, Unknown Primary--mortality<br/>Postoperative Complications--mortality<br/>Prognosis<br/>Prospective Studies<br/>Retrospective Studies<br/>Skin Neoplasms--mortality<br/>Survival Rate